W. Anthony Vernon

Insider Reports History

Entity
Individual
Location
C/O Axovant Sciences, Inc., 320 West 37 Th Street, New York, NY
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by W. Anthony Vernon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NovoCure Ltd Director Ordinary Shares 165K $3.94M $23.89 Jun 4, 2024 Direct
MCCORMICK & CO INC Director Common Stock - Voting 10.5K $792K $75.57 Mar 27, 2024 Direct
MCCORMICK & CO INC Director Restricted Stock Units 1.34K $102K $75.57 Mar 27, 2024 Direct
NovoCure Ltd Director Stock Option (Right to Buy) 6.23K $102K $16.30 Jun 5, 2024 Direct
Nuvation Bio Inc. Director Stock Option (Right to Buy) 201K Sep 3, 2024 Direct
NovoCure Ltd Director Restricted Stock Units 170K Jun 5, 2024 Direct
MCCORMICK & CO INC Director Options - Right to Buy 3.73K Mar 27, 2024 Direct

Insider Reports Filed by W. Anthony Vernon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NUVB Nuvation Bio Inc. Sep 3, 2024 1 $0 4 Sep 5, 2024 Director
NVCR NovoCure Ltd Jun 4, 2024 3 -$23K 4 Jun 6, 2024 Director
MKC MCCORMICK & CO INC Mar 27, 2024 2 $0 4 Mar 29, 2024 Director
MKC MCCORMICK & CO INC Mar 15, 2024 2 $0 4 Mar 19, 2024 Director
NVCR NovoCure Ltd Jun 7, 2023 2 $0 4 Jun 9, 2023 Director
NUVB Nuvation Bio Inc. May 15, 2023 1 $0 4 May 17, 2023 Director
MKC MCCORMICK & CO INC Mar 29, 2023 2 $0 4 Mar 31, 2023 Director
MKC MCCORMICK & CO INC Mar 15, 2023 2 $0 4 Mar 16, 2023 Director
NVCR NovoCure Ltd Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
NUVB Nuvation Bio Inc. May 16, 2022 1 $0 4/A Jun 28, 2022 Director
MKC MCCORMICK & CO INC Mar 30, 2022 2 $0 4 Apr 1, 2022 Director
MKC MCCORMICK & CO INC Mar 15, 2022 2 $0 4 Mar 17, 2022 Director
NUVB Nuvation Bio Inc. Oct 29, 2021 1 $0 4 Nov 2, 2021 Director
NVCR NovoCure Ltd Jun 9, 2021 2 $0 4 Jun 11, 2021 Director